Top Growth Companies With High Insider Ownership On Euronext Paris In September 2024
Reviewed by Simply Wall St
As global markets face renewed fears of an economic slowdown, the French CAC 40 Index has not been spared, declining 3.65% amidst broader European market losses. Despite these challenges, growth companies with high insider ownership remain attractive due to their potential for robust performance and alignment of interests between management and shareholders. In this article, we will explore three such promising stocks listed on Euronext Paris that stand out in September 2024.
Top 10 Growth Companies With High Insider Ownership In France
| Name | Insider Ownership | Earnings Growth |
| Groupe OKwind Société anonyme (ENXTPA:ALOKW) | 24.8% | 36% |
| VusionGroup (ENXTPA:VU) | 13.4% | 25.7% |
| Adocia (ENXTPA:ADOC) | 11.9% | 63% |
| Icape Holding (ENXTPA:ALICA) | 30.2% | 27.3% |
| Arcure (ENXTPA:ALCUR) | 21.4% | 27.5% |
| La Française de l'Energie (ENXTPA:FDE) | 19.9% | 31.9% |
| STIF Société anonyme (ENXTPA:ALSTI) | 16.4% | 28.5% |
| Munic (ENXTPA:ALMUN) | 29.2% | 149.1% |
| MedinCell (ENXTPA:MEDCL) | 15.8% | 93.9% |
| OSE Immunotherapeutics (ENXTPA:OSE) | 25.6% | 5.9% |
We're going to check out a few of the best picks from our screener tool.
Lectra (ENXTPA:LSS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture markets across Northern Europe, Southern Europe, the Americas, and the Asia Pacific with a market cap of €1.04 billion.
Operations: The company generates revenue from the Americas (€172.65 million) and the Asia-Pacific region (€118.54 million).
Insider Ownership: 19.6%
Lectra is a growth company in France with high insider ownership, forecasted to achieve significant earnings growth of 29.3% per year over the next three years, outpacing the French market's 12.3%. Despite its revenue growing at 10.4% annually, slower than some high-growth benchmarks, it remains above the market average of 5.7%. Recent earnings showed sales of €262.29 million for H1 2024 but a slight decline in net income to €12.51 million from €14.47 million last year.
- Dive into the specifics of Lectra here with our thorough growth forecast report.
- Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials.
MedinCell (ENXTPA:MEDCL)
Simply Wall St Growth Rating: ★★★★★☆
Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €493.91 million.
Operations: MedinCell's revenue primarily comes from its pharmaceuticals segment, amounting to €11.95 million.
Insider Ownership: 15.8%
MedinCell, a French growth company with significant insider ownership, is leveraging its BEPO® technology through strategic alliances. A recent collaboration with AbbVie could yield up to $1.9 billion in milestones and royalties on net sales. MedinCell's revenue is forecasted to grow 46.2% annually, significantly outpacing the French market average of 5.7%. Despite a net loss of €25.04 million for the fiscal year ended March 31, 2024, analysts expect profitability within three years.
- Delve into the full analysis future growth report here for a deeper understanding of MedinCell.
- Upon reviewing our latest valuation report, MedinCell's share price might be too pessimistic.
VusionGroup (ENXTPA:VU)
Simply Wall St Growth Rating: ★★★★★★
Overview: VusionGroup S.A. offers digitalization solutions for commerce across Europe, Asia, and North America, with a market cap of €2.20 billion.
Operations: The company generates revenue primarily through installing and maintaining electronic shelf labels, amounting to €801.96 million.
Insider Ownership: 13.4%
VusionGroup, a French growth company with high insider ownership, recently partnered with Ace Hardware to implement its advanced digital shelf label (DSL) technology across over 5,000 U.S. stores. This collaboration enhances operational efficiencies and customer experience through real-time pricing updates and IoT management. Additionally, VusionGroup's earnings are forecasted to grow 25.74% annually, significantly outpacing the French market average of 12.3%, while revenue is expected to increase by 21.3% per year.
- Click here to discover the nuances of VusionGroup with our detailed analytical future growth report.
- Our valuation report here indicates VusionGroup may be overvalued.
Next Steps
- Unlock more gems! Our Fast Growing Euronext Paris Companies With High Insider Ownership screener has unearthed 21 more companies for you to explore.Click here to unveil our expertly curated list of 24 Fast Growing Euronext Paris Companies With High Insider Ownership.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ENXTPA:MEDCL
MedinCell
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
High growth potential and fair value.
